| EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes JJM Van Dongen, L Lhermitte, S Böttcher, J Almeida, ... Leukemia 26 (9), 1908-1975, 2012 | 1042 | 2012 |
| EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols T Kalina, J Flores-Montero, VHJ Van Der Velden, M Martin-Ayuso, ... Leukemia 26 (9), 1986-2010, 2012 | 820 | 2012 |
| Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia P Theunissen, E Mejstrikova, L Sedek, AJ van der Sluijs-Gelling, G Gaipa, ... Blood, The Journal of the American Society of Hematology 129 (3), 347-357, 2017 | 386 | 2017 |
| Toward a NOTCH1/FBXW7/RAS/PTEN–Based Oncogenetic Risk Classification of Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute … A Trinquand, A Tanguy-Schmidt, R Ben Abdelali, J Lambert, K Beldjord, ... Journal of clinical oncology 31 (34), 4333-4342, 2013 | 248 | 2013 |
| Mast cell leukemia S Georgin-Lavialle, L Lhermitte, P Dubreuil, MO Chandesris, O Hermine, ... Blood, The Journal of the American Society of Hematology 121 (8), 1285-1295, 2013 | 209 | 2013 |
| Early response-based therapy stratification improves survival in adult early thymic precursor acute lymphoblastic leukemia: a group for research on adult acute lymphoblastic … J Bond, C Graux, L Lhermitte, D Lara, T Cluzeau, T Leguay, A Cieslak, ... J Clin Oncol 35 (23), 2683-2691, 2017 | 164 | 2017 |
| Genetically distinct leukemic stem cells in human CD34− acute myeloid leukemia are arrested at a hemopoietic precursor-like stage L Quek, GW Otto, C Garnett, L Lhermitte, D Karamitros, B Stoilova, IJ Lau, ... Journal of Experimental Medicine 213 (8), 1513-1535, 2016 | 164 | 2016 |
| Interleukin-15-dependent T-cell-like innate intraepithelial lymphocytes develop in the intestine and transform into lymphomas in celiac disease J Ettersperger, N Montcuquet, G Malamut, N Guegan, S Lopez-Lastra, ... Immunity 45 (3), 610-625, 2016 | 153 | 2016 |
| Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis S Barete, O Lortholary, G Damaj, I Hirsch, MO Chandesris, C Elie, ... Blood, The Journal of the American Society of Hematology 126 (8), 1009-1016, 2015 | 143 | 2015 |
| Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency D Boutboul, HS Kuehn, Z Van de Wyngaert, JE Niemela, I Callebaut, ... The Journal of clinical investigation 128 (7), 3071-3087, 2018 | 139 | 2018 |
| Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study O Lortholary, MO Chandesris, CB Livideanu, C Paul, G Guillet, E Jassem, ... The Lancet 389 (10069), 612-620, 2017 | 119 | 2017 |
| How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? F Garnache-Ottou, C Vidal, S Biichlé, F Renosi, E Poret, M Pagadoy, ... Blood advances 3 (24), 4238-4251, 2019 | 107 | 2019 |
| Flow cytometric immunobead assay for the detection of BCR–ABL fusion proteins in leukemia patients F Weerkamp, E Dekking, YY Ng, VHJ Van der Velden, H Wai, S Böttcher, ... Leukemia 23 (6), 1106-1117, 2009 | 103 | 2009 |
| TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression S Dadi, S Le Noir, D Payet-Bornet, L Lhermitte, J Zacarias-Cabeza, ... Cancer cell 21 (4), 563-576, 2012 | 95 | 2012 |
| ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases G Damaj, M Joris, O Chandesris, K Hanssens, E Soucie, D Canioni, ... PloS one 9 (1), e85362, 2014 | 84 | 2014 |
| Midostaurin in advanced systemic mastocytosis MO Chandesris, G Damaj, D Canioni, C Brouzes, L Lhermitte, ... New England Journal of Medicine 374 (26), 2605-2606, 2016 | 71 | 2016 |
| Amazonia!: an online resource to Google and visualize public human whole genome expression data T Le Carrour, S Assou, S Tondeur, L Lhermitte, N Lamb, T Reme, ... The Open Bioinformatics Journal 4 (1), 2010 | 69* | 2010 |
| Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study M Cheminant, C Derrieux, A Touzart, S Schmit, A Grenier, A Trinquand, ... Haematologica 101 (3), 336, 2016 | 68 | 2016 |
| Clinical proteomics and mass spectrometry profiling for cancer detection J Solassol, W Jacot, L Lhermitte, N Boulle, T Maudelonde, A Mangé Expert review of proteomics 3 (3), 311-320, 2006 | 66 | 2006 |
| Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia JM Ribera, M Morgades, J Ciudad, P Montesinos, J Esteve, E Genescà, ... Blood, The Journal of the American Society of Hematology 137 (14), 1879-1894, 2021 | 62 | 2021 |
